| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/17/2001 | CA2388593A1 Bicyclic and tricyclic heteroaromatic compounds |
| 05/17/2001 | CA2388343A1 Methods for inhibiting neurofibromatosis type 1 (nf1) |
| 05/17/2001 | CA2388008A1 29 human secreted proteins |
| 05/17/2001 | CA2387624A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 05/17/2001 | CA2382676A1 Prevention of plaque rupture by acat inhibitors |
| 05/16/2001 | EP1099754A1 Mesenchymal stem cells and/or progenitor cells, their isolation and use |
| 05/16/2001 | EP1099706A2 Estrane sulphamate derivatives as steroid sulphatase inhibitors |
| 05/16/2001 | EP1099702A1 Substituted morpholine derivatives and their use as therapeutic agents |
| 05/16/2001 | EP1099701A1 7-[(4'-Trifluoromethyl-biphenyl-2-carbonyl)amino]-quinoline-3-carboxylic acid amides, and methods of inhibiting the secretion of apolipoprotein B |
| 05/16/2001 | EP1099695A1 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them |
| 05/16/2001 | EP1099439A2 Use of apo B secretion/MTP inhibitors |
| 05/16/2001 | EP1098985A1 Genes of the dead box protein family, their expression products and use |
| 05/16/2001 | EP1098978A1 Gbs toxin receptor |
| 05/16/2001 | EP1098975A1 Orphan cytokine receptor |
| 05/16/2001 | EP1098974A2 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis |
| 05/16/2001 | EP1098970A1 Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors |
| 05/16/2001 | EP1098960A2 Agents for the immunotherapy of tumoral diseases |
| 05/16/2001 | EP1098908A2 Anti-ccr2 antibodies and methods of use therefor |
| 05/16/2001 | EP1098904A1 Axor10, a g-protein coupled receptor |
| 05/16/2001 | EP1098897A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 05/16/2001 | EP1098896A1 5-bicycloindole compounds |
| 05/16/2001 | EP1098892A1 Biphenyl derivatives |
| 05/16/2001 | EP1098891A1 Polycyclic thiazolidin-2-ylidene amines, method for the production and use thereof as medicaments |
| 05/16/2001 | EP1098889A1 Substituted piperazones and their therapeutic uses |
| 05/16/2001 | EP1098888A1 Piperazinone derivatives and their uses |
| 05/16/2001 | EP1098885A1 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 05/16/2001 | EP1098884A1 Il-8 receptor antagonists |
| 05/16/2001 | EP1098878A1 Bispiperidines as antithrombotic agents |
| 05/16/2001 | EP1098873A1 Alpha-(2-hydroxyphenyl)nitrone compounds, pharmaceutical compositons containing the same and their use for treating inflammation |
| 05/16/2001 | EP1098664A2 Conjugates for treating inflammatory disorders and associated tissue damage |
| 05/16/2001 | EP1098662A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 05/16/2001 | EP1098661A2 Gnrh vaccines for suppressing reproductive behavior in animals |
| 05/16/2001 | EP1098659A2 Libraries of polyhydroxamates and their analogs |
| 05/16/2001 | EP1098656A2 Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof |
| 05/16/2001 | EP1098655A2 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers |
| 05/16/2001 | EP1098652A2 Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound |
| 05/16/2001 | EP1098651A2 Novel urokinase inhibitors |
| 05/16/2001 | EP1098648A1 Pharmaceutical compositions comprising hydroxylansoprazole and uses thereof |
| 05/16/2001 | EP1098647A1 Compounds and compositions for treating tissue ischemia |
| 05/16/2001 | EP1098645A1 Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ards) and infant respiratory distress syndrome (irds) |
| 05/16/2001 | EP1098642A1 Methods for treating conditions modulated by lactosylceramide |
| 05/16/2001 | EP1098639A1 Use of a glucose uptake enhancer for reducing apoptosis |
| 05/16/2001 | EP1098638A1 Use of a glucose uptake enhancer for reducing post-ischemic injury of the heart |
| 05/16/2001 | EP1098634A2 Bioenhanced formulations comprising eprosartan in oral solid dosage form |
| 05/16/2001 | EP1011673B1 Novel niddm regimen |
| 05/16/2001 | EP0842165B1 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents |
| 05/16/2001 | EP0839136B1 BENZO[g]QUINOLINE DERIVATIVES |
| 05/16/2001 | CN1295574A Porphyrins and their use as photosensitizer |
| 05/16/2001 | CN1295571A PDE IV inhibiting pyridine derivatives |
| 05/16/2001 | CN1295565A Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same |
| 05/16/2001 | CN1295563A 2-arylethyl-(piperidin-4-ylmethyl) amine derivatives as muscarinic receptor antagonists |
| 05/16/2001 | CN1295484A Formulations for protection of PEG-interferon alpha conjugates |
| 05/16/2001 | CN1295482A Antagonists of the inflammatory mediator oncostatin M (OSM) |
| 05/16/2001 | CN1295479A Beta 2-adrenergic receptor agonist |
| 05/16/2001 | CN1295473A Use of dexmedetomidine for ICU sedation |
| 05/16/2001 | CN1295471A Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 05/16/2001 | CN1295470A Transdermal terapeutic system which contains D2 agonist and which is provided for treating parkinsonism, and method for production thereof |
| 05/16/2001 | CN1295065A Phenyl heterocyclic compound used as epoxy enzyme -2 inhibitor |
| 05/16/2001 | CN1295064A Novel tricyclic compound and medicine composition containing the same |
| 05/16/2001 | CN1294913A Pharmaceutical use of compound |
| 05/16/2001 | CN1065863C N-substituted dioxothiazolidylbenzamide derivatives and process for producing same |
| 05/16/2001 | CN1065861C Phenyl substituted alkenocarboxylic guanidine, preparation method application as medicine or diagnostic agent and medicine containing it |
| 05/16/2001 | CN1065746C Placenta tonic medicines and prepn. chereof |
| 05/15/2001 | USRE37180 Photochemotherapeutical obstruction of newly-formed blood vessels |
| 05/15/2001 | US6232468 Antiinflammatory agent |
| 05/15/2001 | US6232460 Isolated nucleic acid molecule which encodes an SCP-1 mutein |
| 05/15/2001 | US6232458 Proteins used in pharmaceutical human and veterinary applications; adapted to provide enhanced expression |
| 05/15/2001 | US6232454 Nucleic acid and amino acid sequences and use in diagnosis, treatment, and prevention of cancer and immune disorders |
| 05/15/2001 | US6232445 Soluble MHC complexes and methods of use thereof |
| 05/15/2001 | US6232438 Angiotensin converting enzyme inhibitors |
| 05/15/2001 | US6232350 Administering triphenylethylene antiestrogens (tamoxifen and derivatives-neuroprotectants) to act as cell-nucleus receptor blockers |
| 05/15/2001 | US6232342 Protease inhibitors |
| 05/15/2001 | US6232341 Topical pharmaceutical compositions for healing wounds |
| 05/15/2001 | US6232337 Useful in the treatment of type ii diabetes and obesity |
| 05/15/2001 | US6232336 Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 05/15/2001 | US6232335 2,4-Dioxopyrrolidine and 2,4-dioxotetrahydrofan derivatives and medicines containing the same at the active ingredient |
| 05/15/2001 | US6232330 Therapeutically effective amount of an insulin sensitivity enhancer(pioglitazone,troglitazone and salts) in combination with an aldose reductase inhibitor(tolurestat,epalrestat,imirestat,zenarestat) |
| 05/15/2001 | US6232329 Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles |
| 05/15/2001 | US6232328 Non-systemic control of parasites |
| 05/15/2001 | US6232321 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 05/15/2001 | US6232315 Method for treating inflammatory diseases by administering a thrombin inhibitor |
| 05/15/2001 | US6232314 Arylalkylpiperazine compounds as antioxidants |
| 05/15/2001 | US6232313 Pyridazino quinoline compounds |
| 05/15/2001 | US6232308 Useful for inhibiting bone resorption, treating and preventing osteoporosis, inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, and angiogenesis |
| 05/15/2001 | US6232305 Substituted amino bicyclic-β-lactam penam and cepham derivatives as cysteine protease inhibitors |
| 05/15/2001 | US6232290 Cyclic hexapeptides with antimicrobial activity |
| 05/15/2001 | US6232289 Method of treating interstitial cytitis with recombinant heparin-binding epidermal growth factor-like growth factor (HB-EGF) |
| 05/15/2001 | US6232286 Methods of stimulating mitogenesis in glial cells using glial mitogenic factors |
| 05/15/2001 | US6232118 Nucleic acid encoding a protein of defined amino acid sequence; recombinant cell culture production; diagnosis; probes; treatment of parkinson's disease and other nervous system disorders with reduced side effects; gene therapy |
| 05/15/2001 | US6232097 Nucleotide sequences coding enzymatic polypeptide; prevent bacterial infection; wound healing agents; for vaccine development |
| 05/15/2001 | US6232077 Genetic engineering and expression; cancer diagnosis |
| 05/15/2001 | US6232064 Fibrosis and atherosclerosis determination |
| 05/15/2001 | US6231833 Administering to the mammal for treating serotonin system related disorders an effective amount of 2,7-substituted octahydro-1h-pyrido(1,2-a)pyrazine derivative as ligands for serotonin receptor |
| 05/15/2001 | US6231594 Method of controlling body temperature while reducing shivering |
| 05/15/2001 | CA2238978C Retroviral protease inhibiting compounds |
| 05/15/2001 | CA2180011C Botulinum toxins for treating sweating |
| 05/15/2001 | CA2173729C .delta.16 unsaturated c17 heterocyclic steroids useful as steroid c17-20 lyase inhibitors |
| 05/15/2001 | CA2154663C Polyamine derivatives as radioprotective agents |
| 05/15/2001 | CA2041638C Recombinant polynucleotide constructs suitable for providing secretion of pai-2 |
| 05/15/2001 | CA2034612C Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase |